233 related articles for article (PubMed ID: 30310281)
1. Restriction of H1N1 influenza virus infection by selenium nanoparticles loaded with ribavirin via resisting caspase-3 apoptotic pathway.
Lin Z; Li Y; Gong G; Xia Y; Wang C; Chen Y; Hua L; Zhong J; Tang Y; Liu X; Zhu B
Int J Nanomedicine; 2018; 13():5787-5797. PubMed ID: 30310281
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways.
Li Y; Lin Z; Guo M; Zhao M; Xia Y; Wang C; Xu T; Zhu B
Int J Nanomedicine; 2018; 13():2005-2016. PubMed ID: 29662313
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus.
Li Y; Lin Z; Guo M; Xia Y; Zhao M; Wang C; Xu T; Chen T; Zhu B
Int J Nanomedicine; 2017; 12():5733-5743. PubMed ID: 28848350
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
[TBL] [Abstract][Full Text] [Related]
5. [In vitro and in vivo anti-influenza virus activity of ribavirin injection].
Gao RM; Li XQ; He WY; Jiang JD; Li YH
Yao Xue Xue Bao; 2010 Mar; 45(3):403-7. PubMed ID: 21351521
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
7. Anti-influenza virus effects of crude phenylethanoid glycosides isolated from ligustrum purpurascens via inducing endogenous interferon-γ.
Hu XP; Shao MM; Song X; Wu XL; Qi L; Zheng K; Fan L; Liao CH; Li CY; He J; Hu YJ; Wu HQ; Li SH; Zhang J; Zhang FX; He ZD
J Ethnopharmacol; 2016 Feb; 179():128-36. PubMed ID: 26190352
[TBL] [Abstract][Full Text] [Related]
8. Effects and mechanism of Qingke Pingchuan granules against influenza virus infection.
He L; Cao J; Xie X; Zhang Y; Zhang X; Wang H; Ma L
Arch Virol; 2024 May; 169(6):130. PubMed ID: 38807015
[TBL] [Abstract][Full Text] [Related]
9. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling.
Ling LJ; Lu Y; Zhang YY; Zhu HY; Tu P; Li H; Chen DF
Phytomedicine; 2020 Feb; 67():153150. PubMed ID: 31958713
[TBL] [Abstract][Full Text] [Related]
10. The Inhibition of H1N1 Influenza Virus-Induced Apoptosis by Surface Decoration of Selenium Nanoparticles with β-Thujaplicin through Reactive Oxygen Species-Mediated AKT and p53 Signaling Pathways.
Wang C; Chen H; Chen D; Zhao M; Lin Z; Guo M; Xu T; Chen Y; Hua L; Lin T; Tang Y; Zhu B; Li Y
ACS Omega; 2020 Dec; 5(47):30633-30642. PubMed ID: 33283112
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of a synthesized shikonin ester against influenza A (H1N1) virus and insights into its mechanism.
Zhang Y; Han H; Qiu H; Lin H; Yu L; Zhu W; Qi J; Yang R; Pang Y; Wang X; Lu G; Yang Y
Biomed Pharmacother; 2017 Sep; 93():636-645. PubMed ID: 28688289
[TBL] [Abstract][Full Text] [Related]
12. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary surfactant lipids inhibit infections with the pandemic H1N1 influenza virus in several animal models.
Numata M; Mitchell JR; Tipper JL; Brand JD; Trombley JE; Nagashima Y; Kandasamy P; Chu HW; Harrod KS; Voelker DR
J Biol Chem; 2020 Feb; 295(6):1704-1715. PubMed ID: 31882535
[TBL] [Abstract][Full Text] [Related]
14. Effect of Haoqin Qingdan Tang on influenza A virus through the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway.
Liang S; Lin J; Xiao M; Shi T; Song Y; Zhang T; Zhou X; Li R; Zhao X; Yang Z; Ti H
Phytomedicine; 2024 Jul; 129():155680. PubMed ID: 38728923
[TBL] [Abstract][Full Text] [Related]
15. Synergistic anti-influenza virus A (H1N1) activities of PM-523 (polyoxometalate) and ribavirin in vitro and in vivo.
Shigeta S; Mori S; Watanabe J; Soeda S; Takahashi K; Yamase T
Antimicrob Agents Chemother; 1997 Jul; 41(7):1423-7. PubMed ID: 9210659
[TBL] [Abstract][Full Text] [Related]
16.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
17. [Antiviral effects of the combination of glycyrrhizin and ribavirin against influenza A H1N1 virus infection in vivo].
Chen XX; Zhou HX; Qi WB; Ning ZY; Ma YJ; Li YL; Wang GC; Chen JX
Yao Xue Xue Bao; 2015 Aug; 50(8):966-72. PubMed ID: 26668995
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.
Barnard DL; Wong MH; Bailey K; Day CW; Sidwell RW; Hickok SS; Hall TJ
Antivir Chem Chemother; 2007; 18(3):125-32. PubMed ID: 17626596
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea.
Ling JX; Wei F; Li N; Li JL; Chen LJ; Liu YY; Luo F; Xiong HR; Hou W; Yang ZQ
Acta Pharmacol Sin; 2012 Dec; 33(12):1533-41. PubMed ID: 22941291
[TBL] [Abstract][Full Text] [Related]
20. Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice.
Chen L; Dou J; Su Z; Zhou H; Wang H; Zhou W; Guo Q; Zhou C
Antiviral Res; 2011 Sep; 91(3):314-20. PubMed ID: 21782851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
